A recent study presented at the European Academy of Dermatology and Venereology Congress 2023 has showcased the remarkable capabilities of artificial intelligence (AI) software in detecting melanoma. This AI system demonstrated a stunning 100% accuracy rate in identifying skin cancers, including melanoma, during a two-and-a-half-year evaluation of 22,356 patients.

‍

It also successfully detected 541 out of 585 precancerous lesions (92.5%). These impressive results reflect advancements in AI training techniques and data quality. Despite these achievements, the study emphasizes that AI should complement rather than replace dermatologists and should be used alongside professional medical care.

‍

Although AI has shown immense promise in dermatology, experts caution against using it as a sole detection method. The study points out that one case of basal cell carcinoma was missed by the AI system, highlighting the importance of human dermatologists in the diagnostic process.

‍

Researchers believe that, with appropriate clinical oversight, AI could serve as a valuable triage tool, but its use should be cost-effective and well-integrated into the broader healthcare framework.

‍